SEC Form 4 · accession 0001445064-15-000070
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Angus C. Russell
Director
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 6:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 19, 2015 | A | 1,893 | $0.00 | A | 15,524 | D | |
| Ordinary SharesF1 | Mar 19, 2015 | A | 1,715 | $0.00 | A | 17,239 | D | |
| Ordinary Shares | Mar 19, 2015 | F | 606 | $131.21 | D | 16,633 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | $0.00 | Mar 19, 2015 | A | 1,893 | D | — | — | Ordinary Shares | 1,893 | 0 | D |
Explanation of responses
- F1Consists of restricted stock units that vest in their entirety as of the date of the Company's 2016 Annual General Meeting and settle in ordinary shares upon vesting.
- F2These restricted stock units ("RSUs") were granted to the reporting person in connection with his appointment to the Mallinckrodt board of directors on August 14, 2014. These RSUs vested in their entirety as of the date of Mallinckrodt's 2015 annual general meeting of shareholders (March 19, 2015) and setttled in Mallinckrodt ordinary shares upon vesting.